Oikkonen M, Rosenberg P H
Ann Chir Gynaecol. 1984;73(1):28-33.
A retrospective questionnaire revealed 11 patients with halothane related liver disturbances in Finland in 1972-1981. Seven of the cases were regarded as obvious and two as probable halothane hepatitis (HH). Four patients suffered HH twice, and none of the cases had a fatal outcome. The speed of onset of icterus correlated with the number of halothane exposures, as did the increase in liver enzyme (ASAT, ALAT) activities and the increase in serum bilirubin concentration. Halothane anaesthesia is strictly contraindicated if a nondefinite icterus has appeared after a previous exposure to halothane. It should not be given if unclear fever or prolonged nausea have followed a previous exposure. No major adverse effects or organ toxicity connected with enflurane were found.
一项回顾性问卷调查显示,1972年至1981年期间芬兰有11例与氟烷相关的肝脏功能紊乱患者。其中7例被视为明确病例,2例被视为可能的氟烷性肝炎(HH)。4例患者曾两次患HH,无一例死亡。黄疸出现的速度与氟烷暴露次数相关,肝酶(谷草转氨酶、谷丙转氨酶)活性的升高以及血清胆红素浓度的升高也与之相关。如果在先前接触氟烷后出现不明原因的黄疸,则严格禁止使用氟烷麻醉。如果在先前接触氟烷后出现不明原因的发热或持续性恶心,也不应使用氟烷。未发现与恩氟烷相关的重大不良反应或器官毒性。